Menu Search
Equities

International Stem Cell Corp

ISCO:QBB

International Stem Cell Corp

Actions
  • Price (USD)0.089
  • Today's Change0.009 / 11.95%
  • Shares traded5.00k
  • 1 Year change-35.25%
  • Beta0.1866
Data delayed at least 15 minutes, as of Sep 20 2024 14:30 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year International Stem Cell Corp had revenues fall -4.78% from 8.18m to 7.79m, though the company grew net income from a loss of 331.00k to a smaller loss of 131.00k.
Gross margin58.62%
Net profit margin-8.22%
Operating margin-6.61%
Return on assets-12.02%
Return on equity--
Return on investment-84.86%
More ▼

Cash flow in USDView more

In 2023, International Stem Cell Corp increased its cash reserves by 114.02%, or 846.00k. The company earned 929.00k from its operations for a Cash Flow Margin of 11.93%. In addition the company used 83.00k on investing activities while cash flow from financing was even.
Cash flow per share-0.0612
Price/Cash flow per share--
Book value per share0.0355
Tangible book value per share-0.0592
More ▼

Balance sheet in USDView more

International Stem Cell Corp has a Debt to Total Capital ratio of 92.54%.
Current ratio0.7602
Quick ratio0.4785
Total debt/total equity12.40
Total debt/total capital0.9254
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.